MedTrace Logo

Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos

NCT01754207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-12-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect further data on the safety and efficacy of removing unwanted non cosmetic tattoos (including recalcitrant) using the 755nm Alexandrite laser.

Conditions

  • Tattoos

Interventions

DEVICE

755nm Alexandrite Laser

755nm Alexandrite Laser

DEVICE

755nm Alexandrite Laser with CAP Array

755nm Alexandrite Laser with CAP Array

Sponsors & Collaborators

  • Cynosure, Inc.

    lead INDUSTRY

Principal Investigators

  • Patricia Krantz · Cynosure, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01754207 on ClinicalTrials.gov